MAB8256
Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2
ascites fluid, clone 9B3.2, Chemicon®
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Empfohlene Produkte
Biologische Quelle
mouse
Qualitätsniveau
Antikörperform
ascites fluid
Antikörper-Produkttyp
primary antibodies
Klon
9B3.2, monoclonal
Speziesreaktivität
human
Hersteller/Markenname
Chemicon®
Methode(n)
immunofluorescence: suitable
Isotyp
IgG2a
Versandbedingung
wet ice
Spezifität
Influenza A H1N1 antigen.
• Reacts strongly with all H1N1 strains tested including Beijing, A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97, A/Nanchang /16A/98,A/PR/8/34, New Caledonia strain, and A/California/7/2009.
• No reactivity shown to Influenza B strains.
• Reacts strongly with all H1N1 strains tested including Beijing, A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97, A/Nanchang /16A/98,A/PR/8/34, New Caledonia strain, and A/California/7/2009.
• No reactivity shown to Influenza B strains.
Immunogen
Epitope: H1N1 Antigen
Influenza blend
Anwendung
Research Category
Infektionskrankheiten
Infektionskrankheiten
Research Sub Category
Virale Infektionskrankheiten
Virale Infektionskrankheiten
Anti-Influenza A Antibody, H1N1 Antigen, clone 9B3.2 is an antibody against Influenza A for use in IF.
Indirect Immunofluorescence : 1/32
Physikalische Form
Ascites
Lagerung und Haltbarkeit
Maintain at -20°C. Avoid repeated freeze/thaw cycles.
Rechtliche Hinweise
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Haftungsausschluss
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Produkt-Auswahlhilfe.
Lagerklassenschlüssel
10 - Combustible liquids
WGK
nwg
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Rapid typing, subtyping and RNA quantification of influenza virus type A strains in respiratory secretions.
Elena Percivalle,Francesca Rovida,Antonio Piralla,Vanina Rognoni,Maurizio Zavattoni et al.
The New Microbiologica null
Sreekumar Othumpangat et al.
Pathogens (Basel, Switzerland), 12(1) (2023-01-22)
Understanding the host response to influenza A virus (IAV) infection is vital for developing intervention strategies. The primary barriers for invading respiratory pathogens are the respiratory tract epithelial cells and antimicrobial proteins generated by these cells. The antimicrobial peptide, β-defensin-1
Asami Makino et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31(4), 1301-1322 (2016-08-06)
We identified a novel, nontoxic mushroom protein that specifically binds to a complex of sphingomyelin (SM), a major sphingolipid in mammalian cells, and cholesterol (Chol). The purified protein, termed nakanori, labeled cell surface domains in an SM- and Chol-dependent manner
Brian J Morrison et al.
Journal of virological methods, 248, 7-18 (2017-06-19)
This study describes an antibody-dependent NK cell degranulation assay, as a biomarker to assess antibody-dependent cellular cytotoxicity (ADCC) response in influenza plasma and for antibody therapies against influenza infection. The concentration of neutralizing antibodies (NAbs) against the hemagglutinin receptor of
Amani Audi et al.
Frontiers in microbiology, 11, 612-612 (2020-05-20)
Influenza A virus (IAV) is a major human respiratory pathogen causing annual epidemics as well as periodic pandemics. A complete understanding of the virus pathogenesis and host factors involved in the viral lifecycle is crucial for developing novel therapeutic approaches.
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.